The Chemours Newsroom

RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $25

Moomoo NewsNov 6 07:36 ET

Chemours Is Maintained at Equal-Weight by Morgan Stanley

Dow JonesNov 5 08:32 ET

Chemours Analyst Ratings

BenzingaNov 5 08:22 ET

Barclays Maintains The Chemours(CC.US) With Hold Rating, Raises Target Price to $23

Moomoo NewsNov 5 04:39 ET

Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating

Moomoo NewsNov 5 01:32 ET

Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30

Moomoo NewsNov 4 21:34 ET

Mizuho Securities Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $22

Moomoo NewsOct 14 14:31 ET

RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $28

Moomoo NewsOct 11 09:31 ET

UBS Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $26

Moomoo NewsOct 8 12:31 ET

UBS Adjusts The Chemours Price Target to $26 From $28, Maintains Buy Rating

MT NewswiresOct 7 10:52 ET

Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30

Moomoo NewsOct 7 09:31 ET

BMO Capital Maintains The Chemours(CC.US) With Buy Rating, Raises Target Price to $32

Moomoo NewsOct 7 07:31 ET

Navigating 7 Analyst Ratings For Chemours

BenzingaSep 25 12:00 ET

Chemours Is Maintained at Equal-Weight by Barclays

Dow JonesSep 25 11:50 ET

Barclays Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $21

Moomoo NewsSep 25 05:33 ET

Goldman Sachs Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $23

Moomoo NewsSep 3 12:31 ET

Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30

Moomoo NewsAug 6 09:33 ET

Chemours Analyst Ratings

BenzingaAug 6 07:55 ET

BMO Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $30

Moomoo NewsAug 6 07:35 ET

Barclays Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $22

Moomoo NewsAug 6 06:31 ET